Sally had a nice write up about NKTR-214's SITC presentation. I don't know if it was supposed to be behind the paywall or not but I saw a tweet to it and it seems freely available. Its a very nice discussion with interview and I can see why her sub is worthwhile for those with the interest/resources in Oncology drugs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.